Skip to content
Home/Companies/Biotech/Orakl
Orakl

Orakl

Biotech·France·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns Orakl?

Orakl is a French Biotech company, currently owned by Elephants & Ventures / Hardware Club since 2023.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
Elephants & Ventures / Hardware Club
Investor
Elephants & Ventures / Hardware Club
HCVC Hardware Club Fund II · 2023 · VC

Key facts

HQFrance
SectorBiotech
Websitewww.orakl-oncology.com

More from HCVC Hardware Club Fund II

Other portfolio companies in the same fund.

Invoke Bio
Active
BiotechUnited States
Exclaim Robotics
Active
Deep TechSwitzerland· 2026
Karavela
Karavela
Active
AI/MLFrance· 2025
Kyron.bio
Active
BiotechFrance· 2025
Lendurai
Active
FintechEstonia· 2025
Cosmic Robotics
Cosmic Robotics
Active
ClimateTechUS· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Orakl?

Orakl is currently owned by Elephants & Ventures / Hardware Club, through HCVC Hardware Club Fund II, since 2023.

When did Elephants & Ventures / Hardware Club acquire Orakl?

Elephants & Ventures / Hardware Club acquired Orakl in 2023.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue